CAG Q1 2026 Earnings EPS Misses Estimates but Stock Edges Higher Braskem Q1 2026 Earnings Massive EPS Surprise as Company Posts 181 Profit vs Expected Loss ABBV Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips PostRelease Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses SPG Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Higher AXIA Q1 2026 Earnings EPS Misses Estimates Shares Slide 234